6.5
BIOGEN INC. (BIIB)
Health Care / Biotechnology
$183.26
Middle of the pack. No strong signal either way.
Hold
Score based on 5 of 5 models — high confidence
Key Metrics
P/E20.9ROE-651.7Market Cap27B
Estimated Fair Value
$278.0834% below
Fair value above market price. P/E of 21x is moderate for this quality level.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Neutral
PEG 2.0 · Stalwart
Greenblatt
Attractive
Bottom half (rank 56%)
Similar Stocks
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer